Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Hormonal aspects of prostatic cancer: a review.

× No keyword cloud information.

50 in total

1. Bilateral Adrenalectomy in Prostatic Cancer: Clinical Features and Urinary Excretion of 17-Ketosteroids and Estrogen.

Authors: C Huggins; W W Scott
Journal: Ann Surg Date: 1945-12 Impact factor: 12.969

Review 2. Pituitary gonadotrophins.

Authors: P Franchimont
Journal: Clin Endocrinol Metab Date: 1977-03

3. Synthetic analogs of the hypothalamic luteinizing hormone releasing factor with increased agonist or antagonist properties.

Authors: M W Monahan; M S Amoss; H A Anderson; W Vale
Journal: Biochemistry Date: 1973-11-06 Impact factor: 3.162

4. Advanced carcinoma of the prostate: treatment with a gonadotrophin releasing hormone agonist.

Authors: J M Allen; J P O'Shea; K Mashiter; G Williams; S R Bloom
Journal: Br Med J (Clin Res Ed) Date: 1983-05-21

5. Combined treatment with ketoconazole and luteinising hormone releasing hormone analogue: a novel approach to resistant progressive prostatic cancer.

Authors: J M Allen; D J Kerle; H Ware; A Doble; G Williams; S R Bloom
Journal: Br Med J (Clin Res Ed) Date: 1983-12-10

Review 6. Carcinoma of the prostate: a review.

Authors: W J Catalona; W W Scott
Journal: J Urol Date: 1978-01 Impact factor: 7.450

7. Countercurrent distribution as a tool for purification of hypothalamic hormones on a preparative scale.

Authors: A V Schally; R M Nair; W H Carter
Journal: Anal Chem Date: 1971-09 Impact factor: 6.986

8. Tumor growth inhibition in patients with prostatic carcinoma treated with luteinizing hormone-releasing hormone agonists.

Authors: G Tolis; D Ackman; A Stellos; A Mehta; F Labrie; A T Fazekas; A M Comaru-Schally; A V Schally
Journal: Proc Natl Acad Sci U S A Date: 1982-03 Impact factor: 11.205

Hormonal aspects of prostatic cancer: a review.

1. Bilateral Adrenalectomy in Prostatic Cancer: Clinical Features and Urinary Excretion of 17-Ketosteroids and Estrogen.

Review 2. Pituitary gonadotrophins.

3. Synthetic analogs of the hypothalamic luteinizing hormone releasing factor with increased agonist or antagonist properties.

4. Advanced carcinoma of the prostate: treatment with a gonadotrophin releasing hormone agonist.

5. Combined treatment with ketoconazole and luteinising hormone releasing hormone analogue: a novel approach to resistant progressive prostatic cancer.

Review 6. Carcinoma of the prostate: a review.

7. Countercurrent distribution as a tool for purification of hypothalamic hormones on a preparative scale.

8. Tumor growth inhibition in patients with prostatic carcinoma treated with luteinizing hormone-releasing hormone agonists.

9. Therapeutic potential of the LHRH agonist, ICI 118630, in the treatment of advanced prostatic carcinoma.

10. Gynecomastia with ketoconazole.

Review 1. The endocrine effects of ketoconazole.

Review 2. Influence of sex hormones on pancreatic cancer.

3. Chromosome study of five cancers of the prostate.

Review 4. Androgen influence on exocrine pancreatic cancer.

5. Osteoclast inhibition by pamidronate in metastatic prostate cancer: a preliminary study.